相关实验视频
Updated: Jul 26, 2025

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.8K
血和脑脊液的非酶蛋白损伤在阿尔茨海默病中持续存在
Farida Dakterzada1, Mariona Jové2, José Luís Cantero3
1Cognitive Disorders Unit, Clinical Neuroscience Research, Hospital Universitari Santa Maria, IRBLleida, Lleida, Spain.
Redox biology
|June 20, 2023
概括
血液和脑脊液中的氧化损伤标志物与阿尔茨海默病 (AD) 诊断或进展无关. 这表明与AD相关的氧化应激直接影响细胞,而不是通过这些液体.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 老年学是一门学科.
背景情况:
- 氧化压力与阿尔茨海默氏症 (AD) 病原发生有关.
- 对蛋白质的氧化损伤可能导致神经元功能障碍和AD的认知衰退.
- 关于阿尔茨海默病患者的全身和中央液体氧化损伤的研究有限.
研究的目的:
- 测量AD连续体内的血和脑脊液 (CSF) 中的非酶蛋白损伤.
- 评估蛋白质损伤标志物与从轻度认知障碍 (MCI) 到AD的临床进展之间的关系.
主要方法:
- 使用同位素稀释气体染色学――质谱学 (SIM-GC/MS) 在血和脑脊液中的量化非酶性蛋白质修饰标记.
- 研究了289名参与者:103人患有AD,92人患有MCI,94人对照.
- 对年龄,性别,APOE ε4等位基因和CSFAD生物标志物进行控制.
主要成果:
- 在对共变量进行控制后,血或脑液蛋白损伤标志物与AD或MCI诊断之间没有发现关联.
- 脊髓中蛋白质损伤标志物与脊髓中AD生物标志物没有相关性.
- 无论是血还是脑液蛋白损伤水平都与MCI与AD进展无关.
结论:
- 缺乏相关性表明,AD中的氧化损伤局部存在于细胞/组织水平.
- 细胞外液体标记物可能不能准确地反映体内氧化损伤,导致AD.
- 需要进一步的研究,以了解氧化应激在AD中的确切作用和位置.
相关概念视频
Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Cerebrospinal Fluid
2.4K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
2.4K

